CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 31, 2022		95,021,760
Balance at beginning of period at Dec. 31, 2022	$ 2,798,389	$ 933	$ 2,362,663	$ 700,040	$ (265,247)
Increase (Decrease) in Stockholders' Equity
Net income	120,198			120,198
Other comprehensive income (loss)	(10,220)				(10,220)
Cash dividends declared	(62,969)			(62,969)
Dividend equivalents declared	0		244	(244)
Share-based compensation expense	9,272		9,272
Issuance of restricted stock, net (in shares)		1,074,073
Issuance of restricted stock, net	0	$ 4	(4)
Restricted stock surrendered and canceled (in shares)		(205,086)
Restricted stock surrendered and canceled	(5,782)		(5,782)
Exercise of stock options (in shares)		15,470
Exercise of stock options	246		246
Balance at end of period (in shares) at Jun. 30, 2023		95,906,217
Balance at end of period at Jun. 30, 2023	2,849,134	$ 937	2,366,639	757,025	(275,467)
Balance at beginning of period (in shares) at Mar. 31, 2023		95,714,777
Balance at beginning of period at Mar. 31, 2023	2,831,161	$ 937	2,361,830	731,123	(262,729)
Increase (Decrease) in Stockholders' Equity
Net income	57,636			57,636
Other comprehensive income (loss)	(12,738)				(12,738)
Cash dividends declared	(31,612)			(31,612)
Dividend equivalents declared	0		122	(122)
Share-based compensation expense	4,543		4,543
Issuance of restricted stock, net (in shares)		239,349
Issuance of restricted stock, net	0
Restricted stock surrendered and canceled (in shares)		(62,911)
Restricted stock surrendered and canceled	(91)		(91)
Exercise of stock options (in shares)		15,002
Exercise of stock options	235		235
Balance at end of period (in shares) at Jun. 30, 2023		95,906,217
Balance at end of period at Jun. 30, 2023	$ 2,849,134	$ 937	2,366,639	757,025	(275,467)
Balance at beginning of period (in shares) at Dec. 31, 2023	95,860,092	95,860,092
Balance at beginning of period at Dec. 31, 2023	$ 2,882,581	$ 938	2,377,131	604,137	(99,625)
Increase (Decrease) in Stockholders' Equity
Net income	88,930			88,930
Other comprehensive income (loss)	9,492				9,492
Cash dividends declared	(63,458)			(63,458)
Dividend equivalents declared	0		268	(268)
Share-based compensation expense	10,884		10,884
Issuance of restricted stock, net (in shares)		806,001
Issuance of restricted stock, net	0	$ 3	(3)
Restricted stock surrendered and canceled (in shares)		(243,472)
Restricted stock surrendered and canceled	(4,852)		(4,852)
Exercise of stock options (in shares)		11,426
Exercise of stock options	$ 187		187
Balance at end of period (in shares) at Jun. 30, 2024	96,434,047	96,434,047
Balance at end of period at Jun. 30, 2024	$ 2,923,764	$ 941	2,383,615	629,341	(90,133)
Balance at beginning of period (in shares) at Mar. 31, 2024		96,459,966
Balance at beginning of period at Mar. 31, 2024	2,902,801	$ 941	2,378,171	619,405	(95,716)
Increase (Decrease) in Stockholders' Equity
Net income	41,905			41,905
Other comprehensive income (loss)	5,583				5,583
Cash dividends declared	(31,823)			(31,823)
Dividend equivalents declared	0		146	(146)
Share-based compensation expense	5,434		5,434
Issuance of restricted stock, net (in shares)		19,500
Issuance of restricted stock, net	0
Restricted stock surrendered and canceled (in shares)		(46,585)
Restricted stock surrendered and canceled	(161)		(161)
Exercise of stock options (in shares)		1,166
Exercise of stock options	$ 25		25
Balance at end of period (in shares) at Jun. 30, 2024	96,434,047	96,434,047
Balance at end of period at Jun. 30, 2024	$ 2,923,764	$ 941	$ 2,383,615	$ 629,341	$ (90,133)